Mastocytosis clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
(Summit) a Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients with Indolent or Smoldering Systemic Mastocytosis
Sorry, in progress, not accepting new patients
This is a multi-part, randomized, double-blind, placebo-controlled Phase 2 clinical study comparing the safety and efficacy of bezuclastinib (CGT9486) plus best supportive care (BSC) with placebo plus BSC in patients with nonadvanced systemic…
at UCLA
Last updated: